These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 25097977)

  • 1. [The indices of quality of the donor's plasma, obtained by the methods of plasmapheresis and primary fractionation, using various hemopreservatives and leukocytic filters].
    Malyhon OI; Novak VL
    Klin Khir; 2014 Apr; (4):43-5. PubMed ID: 25097977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticoagulation, bleeding, and clotting at donor plasmapheresis.
    Evers J; Taborski U
    J Clin Apher; 2018 Aug; 33(4):538-540. PubMed ID: 29575131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Donor selection for the production of factor XIII preparations].
    Uteg KH; Tausendfreund K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(3):447-55. PubMed ID: 2414175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Blood coagulation and fibrinolysis in blood donors after plasmapheresis].
    Zukowska B; Kotschy M
    Pol Tyg Lek; 1992 Feb 3-10; 47(5-6):120-2. PubMed ID: 1437797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor safety in plasmapheresis.
    Lundsgaard-Hansen P
    Dev Biol Stand; 1980; 48():287-95. PubMed ID: 7274560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor VIII, factor IX and fibrinogen content in cryoprecipitate, fresh plasma and cryoprecipitate-removed plasma.
    Bejrachandra S; Chandanayingyong D; Visudhiphan S; Tumliang S; Kaewkamol K; Siribunrit U
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():162-4. PubMed ID: 7886562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor VIII collection by pheresis.
    McLeod BC; Sassetti RJ; Cole ER; Pierce MI
    Lancet; 1980 Sep; 2(8196):671-3. PubMed ID: 6106786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of residual platelet count on routine coagulation, factor VIII, and factor IX testing in postfreeze-thaw samples.
    Lippi G; Rossi R; Ippolito L; Zobbi V; Azzi D; Pipitone S; Favaloro EJ; Funk DM
    Semin Thromb Hemost; 2013 Oct; 39(7):834-9. PubMed ID: 24022807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The current status of blood fractionation in the United States.
    Sgouris JT
    Vox Sang; 1972; 23(1):45-55. PubMed ID: 5081014
    [No Abstract]   [Full Text] [Related]  

  • 10. [The effect of repeated plasmapheresis on the donor's organism].
    Konstantinov VN; Kurenkova LV; Zaĭtseva LV
    Probl Gematol Pereliv Krovi; 1971 Aug; 16(8):25-7. PubMed ID: 5126394
    [No Abstract]   [Full Text] [Related]  

  • 11. [Measurements of the activity of the coagulation factors VIII:C, IX,XI, and XII in cats].
    Mischke R; Deniz A; Nolte I
    Zentralbl Veterinarmed A; 1995 Oct; 42(8):513-20. PubMed ID: 8592897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of six commercial plasma references for factor VIII, factor IX and von Willebrand factor. On behalf of the Subcommittee for Factor VIII and IX of the Scientific and Standardization Committee of the ISTH.
    Kasper CK; Aronson DL; Davignon G; Foster P; Hillman-Wiseman C; Lusher JM; Manco-Johnson M; Meade JB; Montgomery RR; Rickles FR
    Thromb Haemost; 1995 Sep; 74(3):987-9. PubMed ID: 8571334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Subcutaneous administration of desmopressin to plasma donors: a controlled study].
    Palacios S; Zuazu I; Candela MJ; Rivera J; Vicente V
    Med Clin (Barc); 1995 Oct; 105(14):525-7. PubMed ID: 8523926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Standardization of the thromboplastin generation test for the determination of antihemophilic globulin A (VIII) and B (IX)].
    Bergmann A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1970; 93(3):376-80. PubMed ID: 4195285
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasma fractionation in blood transfusion service.
    Haskó F; Salamon M; Bartha K; Dobó P
    Dev Biol Stand; 1987; 67():39-48. PubMed ID: 3111912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of factor VIII:C and factor IX sensitivity of different commercial APTT reagents for canine plasma].
    Mischke R
    Berl Munch Tierarztl Wochenschr; 1999; 112(10-11):394-9. PubMed ID: 10598358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of filtration on residual levels of coagulation factors in plasma.
    Alhumaidan HS; Cheves TA; Holme S; Sweeney JD
    Am J Clin Pathol; 2013 Jan; 139(1):110-6. PubMed ID: 23270906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening of factor VIII:C levels in blood donors.
    Carlebjörk G; Blombäck M; Blomstedt M; Akerblom O
    Vox Sang; 1986; 51(4):306-9. PubMed ID: 3099471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Determination of prothromboplastin factors (Factors VIII, IX, XI and XII)].
    Kagami M
    Nihon Rinsho; 1976; 34 suppl():2407-24. PubMed ID: 792517
    [No Abstract]   [Full Text] [Related]  

  • 20. Factor assay (VIII and IX) results in the College of American Pathologists Survey Program (1980-1982).
    Christensen RL; Triplett DA
    Am J Clin Pathol; 1983 Oct; 80(4 Suppl):633-42. PubMed ID: 6414289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.